Metabolomics Market 2018 Global Industry Size, Segments, Share and Growth Factor Analysis Research Report 2021

The Market Research on Metabolomics, By Considering useful aspects like; Application, End Users- Global Future Forecast till 2021, published by MarketsandMarkets™, the report studies the global Metabolomics market over the forecast period to 2021. The market is projected to reach USD 2.39 Billion by 2021 at a CAGR of 14.6%.

The study estimates the Metabolomics market size for 2018 and projects its demand till 2021. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include research scientists, Metabolomics specialists, laboratory technicians, and R&D professionals of pharmaceutical and biotechnology companies and academic research institutes.

In this report, the market is segmented on the basis of product & service, application and indication available in the metabolomics market. This report also provides market information on major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The report provides an insight on the metabolomics product matrix which presents a comparative analysis of product portfolios of leading market players. Moreover, the vendor benchmarking provided in the report illustrates the comparison between the geographic and product strength of top companies.

For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the Metabolomics market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The Metabolomics market is fragmented with the presence of emerging players;

The global metabolomics market is dominated by large market players such as Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S)…..Read More

Request a Sample Copy of “Metabolomics Market” Consist 188 tables and 42 figures spread over 259 pages and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=900

Metabolomics Market, by Product & Service;

· Metabolomic Instruments

· Metabolomic Bioinformatics Tools and Services

Metabolomics Market, by Indication;

Cancer
Cardiovascular Disorders
Neurological disorders

Metabolomics Market, by Application;

Biomarker Discovery
Drug Discovery/Drug Assessment
Nutrigenomics

Metabolomics Market, by Region;

· North America (US, Canada)

· Europe (UK, Germany, Others)

· Asia

· Rest of the World

For any queries Speak to our Analyst:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=900

Major Key Points from Table of Content:

· Introduction

· Research Methodology

· Metabolomics Market, By Product & Service

· Metabolomics Market, By Application

· Technology Investment Potential

· Competitive Landscape

· Company Profiles

The Objectives Covered in This Research Report:

-To define, describe, and forecast the global Metabolomics market based on product, application, end user, and region
-To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, -opportunities and industry-specific challenges)
-To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
-To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders.

Major Key Points from List of Tables (Consist of 188 Tables):

· Availability of Government and Private Funding to Drive the Market Growth

· Biomarker Development to Offer Significant Opportunities for Market Growth

· Global Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)

· Global Bioinformatics Tools & Databases Market Size, By Country, 2014–2021 (USD Million)

· Global Metabolomics Market Size for Personalized Medicine Applications, By Country, 2014–2021 (USD Million)

· North America: Metabolomics Instruments Market Size for Separation Tools, By Type, 2021 (USD Million)

· U.S.: Metabolomics Market Size, By Product & Service, 2021 (USD Million)

· Canada: Metabolomics Market Size, By Indication, 2021 (USD Million)

· Europe: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2021 (USD Million)……. Click To Read Full Toc

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=900

Major Key Points from List of Figures (Consist of 42 Figures):

· Global Metabolomics Market, By Product & Service, 2016 vs 2021 (USD Million)

· Global Metabolomics Market, By Indication, 2016 vs 2021 (USD Million)

· Availability of Government and Private Funding for Research is Driving Growth of the Metabolomics Market

· Asia-Pacific to Register Highest Growth During the Forecast Period

· Global Metabolomics Market- Investment Client Network

· Global Metabolomics Market: Geographical Snapshot

· Danaher Corporation: Company Snapshot

· Thermo Fisher Scientific Inc.: Company Snapshot

· Waters Corporation: Company Snapshot

About MarketsandMarkets™ -

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: [email protected]